VHCP Management as of March 31, 2014
Portfolio Holdings for VHCP Management
VHCP Management holds 16 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gw Pharmaceuticals Plc ads | 19.9 | $38M | 644k | 59.37 | |
| Anacor Pharmaceuticals In | 16.1 | $31M | 1.5M | 20.01 | |
| BioCryst Pharmaceuticals (BCRX) | 9.6 | $19M | 1.7M | 10.58 | |
| Dyax | 9.3 | $18M | 2.0M | 8.98 | |
| Keryx Biopharmaceuticals | 8.9 | $17M | 1.0M | 17.04 | |
| Heron Therapeutics (HRTX) | 7.9 | $15M | 1.1M | 13.91 | |
| Dbv Technologies | 6.2 | $12M | 480k | 24.96 | |
| Ironwood Pharmaceuticals (IRWD) | 5.8 | $11M | 900k | 12.32 | |
| Ocera Therapeutics | 3.9 | $7.4M | 704k | 10.55 | |
| Flamel Technologies | 3.5 | $6.7M | 500k | 13.40 | |
| Therapeuticsmd | 2.8 | $5.3M | 847k | 6.31 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $4.9M | 304k | 16.10 | |
| Chelsea Therapeutics International | 2.3 | $4.4M | 788k | 5.52 | |
| Alexza Pharmaceuticals | 0.6 | $1.1M | 248k | 4.43 | |
| Xencor (XNCR) | 0.5 | $1.0M | 88k | 11.73 | |
| Versartis | 0.3 | $571k | 19k | 30.05 |
